[Bidet P, Lalande V, Salauze B, et al. Comparison of PCR-Ribotyping, Arbitrarily PCR and Pulse-Field Gel Electrophoresis for Typing Clostridium difficile // J Clin Microbiol, 2000; 38:2484-248710.1128/JCM.38.7.2484-2487.20008694910878030]Search in Google Scholar
[Biller P, Shank B, Lind L, et al. Moxifloxacin Therapy as a Risk Factor for Clostridium difficile-Associated Disease During an Outbreak: Attempts to Control a New Epidemic Strain // Infect Control Hosp Epidemiol, 2007; 28:199-20110.1086/51178917265402]Search in Google Scholar
[Bouza E, Burillo A, Munoz P. Antimicrobial Therapy of Clostridium difficile-Associated Diarrhea // Med Clin North America, 2006; 90:1141-116310.1016/j.mcna.2006.07.01117116441]Search in Google Scholar
[Chandler R E, Hedberg K, Cieslak R. Clostridium difficile-Associated Disease in Oregon: Increasing Incidence and Hospital-level Risk factor // Infect Control Hosp Epidemiol, 2007; 28:116-12210.1086/51179517265391]Search in Google Scholar
[Clifford L, Coignard B. Recommendations for Surveilance of Clostridium difficile-Associated Disease // Infect Control Hosp Epidemiol, 2007; 28: 140-14510.1086/51179817265394]Search in Google Scholar
[Coignard B, Barbut F, Blanckaert K, et al. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease // Euro Surveill, 2006; 11: pii=06091410.2807/esw.11.37.03044-en17075146]Search in Google Scholar
[Daniel E, Ballard D. Clostridium difficile Toxins: Mechanism of Action and Role in Disease // CMR, 2005; 18:247-26310.1128/CMR.18.2.247-263.2005108279915831824]Search in Google Scholar
[Delme M, Ramboer I, Van Broeck I, et al. Epidemiology of Clostridium difficile toxinotype III, PCR-ribotype 027 associated disease in Belgium // Euro Surveill, 2006; 11:304510.2807/esw.11.37.03045-en17075147]Search in Google Scholar
[Gerding N, Johnson S, Peterson R, et al. Clostridium difficile-associated diarrhea and colitis // Infect Control Hosp Epidemiol, 1995; 16:459-47710.1086/6483637594392]Search in Google Scholar
[Indra A, Huhulescu S, Hasenberger P, et al. First isolation of Cl. difficile PCR ribotype 027 in Austria // Euro Surveill, 2006; 11:pii=304610.2807/esw.11.37.03046-en17075148]Search in Google Scholar
[Kelly P, Pothoulakis C, LaMont T. Clostridium difficile colitis // NEJM, 1991; 330:257-26210.1056/NEJM199401273300406]Search in Google Scholar
[Killgore G, Thompson A, Johnson S, et al. Comparision of Seven Technigues for Typing International Epidemic Strains of Clostridium difficile: REA, PFGE, PCR-ribotyping, MLST, MLVA, AFLP, and slpAST // J Clin Microbiol, 2008; 46: 432-43710.1128/JCM.01484-07]Search in Google Scholar
[Kuijper J, Coignard B, Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe // CMI, 2006; 12:2-1810.1111/j.1469-0691.2006.01580.x]Search in Google Scholar
[Kuijper J, Surawicz M. Clostridium difficile infection // Lancet, 2008; 371:1486-148810.1016/S0140-6736(08)60635-2]Search in Google Scholar
[Lemee L, Bourgeois I, Ruffin E, et al. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekiping genes of Clostridium difficile // J Clin Microbiol, 2005; 46:3171-318010.1099/mic.0.28155-016207902]Search in Google Scholar
[Lemee L, Dhalluin A, Pestel-Caron M, et al. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types // J Clin Microbiol, 2004; 28: 2609-161710.1128/JCM.42.6.2609-2617.200442785415184441]Search in Google Scholar
[Long S, Fenebon L, Fitzgerald S, et al. First isolation and report of cluusters of C.difficile PCR 027 cases in Ireland // Euro Surveill, 2007; 12:pii=318310.2807/esw.12.17.03183-en17868610]Search in Google Scholar
[Pepin J, Valquette L, Alary E, et al. Clostridium difficile-Associated diarrhea in a region of Quebec from 1991 to 2003: a cahgning pattern of disease severity // CMAJ, 2004; 171:466-47210.1503/cmaj.104110451464315337727]Search in Google Scholar
[Pepin J, Valiguette L, Cossete B. Mortality attributall to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec // CMAJ, 2005; 170:1037-104210.1503/cmaj.050978126632616179431]Search in Google Scholar
[Poxton R, McCouberey J, Blair G. The pathogenicity of Clostridium difficile // Clin Microbiol Infect, 2001; 7:421-42710.1046/j.1198-743x.2001.00287.x11591205]Search in Google Scholar
[Rupnik M, Aveseni V, Janc M, et al. Toxinotyping Schema and Correlation of Toxinotypes with Serogroups of Clostridium difficile Isolates // J Clin Microbiol, 1998; 23:2240-224710.1128/JCM.36.8.2240-2247.19981050259665999]Search in Google Scholar
[Soes L, Mollak K, Trobek S, et al. The emergence of Cl. difficile PCR Ribotype 027 in Denmark // Euro Surveill, 2009; 14:19183]Search in Google Scholar
[Tachon M, Cattone C, K. Balanckaert, et al. First cluster of Clostridium.difficile toxinotype III, PCR-ribotype 27 associated disease in France: prelimunary report // Euro Surveill, 2006; 11:2951]Search in Google Scholar